Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection
Noah Kojima, Nabin K. Shrestha, Jeffrey D. Klausner
Evaluation & the Health Professions (2021) Vol. 44, Iss. 4, pp. 327-332
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
Caroline Stein, Hasan Nassereldine, Reed J D Sorensen, et al.
The Lancet (2023) Vol. 401, Iss. 10379, pp. 833-842
Open Access | Times Cited: 309
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 233
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S
Jerald Sadoff, Glenda Gray, An Vandebosch, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 9, pp. 847-860
Open Access | Times Cited: 200
Duration of immune protection of SARS-CoV-2 natural infection against reinfection
Hiam Chemaitelly, Nico Nagelkerke, Houssein H. Ayoub, et al.
Journal of Travel Medicine (2022) Vol. 29, Iss. 8
Open Access | Times Cited: 90
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 82
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study
Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 7, pp. 816-827
Open Access | Times Cited: 70
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 67
Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, et al.
Nature (2025)
Open Access | Times Cited: 2
COVID-19 vaccine strategies must focus on severe disease and global equity
Peter McIntyre, Rakesh Aggarwal, Ilesh Jani, et al.
The Lancet (2021) Vol. 399, Iss. 10322, pp. 406-410
Open Access | Times Cited: 78
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
PLoS Medicine (2021) Vol. 18, Iss. 12, pp. e1003879-e1003879
Open Access | Times Cited: 64
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 12, pp. e944-e955
Open Access | Times Cited: 59
Waning effectiveness of COVID-19 vaccines
Hiam Chemaitelly, Laith J. Abu‐Raddad
The Lancet (2022) Vol. 399, Iss. 10327, pp. 771-773
Open Access | Times Cited: 53
Observed protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR-test data
Daniela Michlmayr, Christian Holm Hansen, Sophie Gubbels, et al.
The Lancet Regional Health - Europe (2022) Vol. 20, pp. 100452-100452
Open Access | Times Cited: 52
Effect of prior infection, vaccination, and hybrid immunity against symptomatic BA.1 and BA.2 Omicron infections and severe COVID-19 in Qatar
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 40
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
EBioMedicine (2023) Vol. 95, pp. 104734-104734
Open Access | Times Cited: 32
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022
Noah Kojima, Katherine Adams, Wesley H. Self, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 4, pp. 547-557
Open Access | Times Cited: 26
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design
Houssein H. Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
American Journal of Epidemiology (2023) Vol. 193, Iss. 6, pp. 883-897
Open Access | Times Cited: 25
Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination
Véronique Barateau, Loïc Peyrot, Carla Saade, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 687
Open Access | Times Cited: 23
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 49
Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022
Jonathan Bastard, Benjamin Taisne, Julie Figoni, et al.
Eurosurveillance (2022) Vol. 27, Iss. 13
Open Access | Times Cited: 34
SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6272-6272
Open Access | Times Cited: 33
SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants
Osman Özüdoğru, Yasemin Genç Bahçe, Ömer Acer
Irish Journal of Medical Science (1971 -) (2022) Vol. 192, Iss. 2, pp. 751-756
Open Access | Times Cited: 32
Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant
Heba N. Altarawneh, Hiam Chemaitelly, Patrick Tang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults
Lior Rennert, Zichen Ma, Christopher S. McMahan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 28
Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design
Houssein H. Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top